- Home
- PRAX vs BELFA Comparison
PRAX vs BELFA Comparison
Compare PRAX & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- BELFA
- Stock Information
- Founded
- PRAX 2015
- BELFA 1949
- Country
- PRAX United States
- BELFA United States
- Employees
- PRAX N/A
- BELFA N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- BELFA
- Sector
- PRAX Health Care
- BELFA
- Exchange
- PRAX Nasdaq
- BELFA Nasdaq
- Market Cap
- PRAX 1.2B
- BELFA 1.3B
- IPO Year
- PRAX 2020
- BELFA N/A
- Fundamental
- Price
- PRAX $74.92
- BELFA $104.90
- Analyst Decision
- PRAX Strong Buy
- BELFA
- Analyst Count
- PRAX 9
- BELFA 0
- Target Price
- PRAX $144.11
- BELFA N/A
- AVG Volume (30 Days)
- PRAX 295.5K
- BELFA 14.6K
- Earning Date
- PRAX 11-05-2024
- BELFA 10-23-2024
- Dividend Yield
- PRAX N/A
- BELFA 0.23%
- EPS Growth
- PRAX N/A
- BELFA N/A
- EPS
- PRAX N/A
- BELFA 5.20
- Revenue
- PRAX $1,771,000.00
- BELFA $559,987,000.00
- Revenue This Year
- PRAX N/A
- BELFA N/A
- Revenue Next Year
- PRAX N/A
- BELFA $10.23
- P/E Ratio
- PRAX N/A
- BELFA $20.01
- Revenue Growth
- PRAX 20.97
- BELFA N/A
- 52 Week Low
- PRAX $13.01
- BELFA $38.82
- 52 Week High
- PRAX $75.73
- BELFA $105.60
- Technical
- Relative Strength Index (RSI)
- PRAX 71.35
- BELFA 66.47
- Support Level
- PRAX $60.73
- BELFA $102.87
- Resistance Level
- PRAX $65.87
- BELFA $105.60
- Average True Range (ATR)
- PRAX 3.85
- BELFA 2.16
- MACD
- PRAX 1.22
- BELFA -0.13
- Stochastic Oscillator
- PRAX 96.03
- BELFA 91.66
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About BELFA Bel Fuse Inc.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.